Synopsis
0
KDMF
0
NDC API
0
VMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
21
PharmaCompass offers a list of Ammonium Glycyrrhizinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ammonium Glycyrrhizinate manufacturer or Ammonium Glycyrrhizinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ammonium Glycyrrhizinate manufacturer or Ammonium Glycyrrhizinate supplier.
PharmaCompass also assists you with knowing the Ammonium Glycyrrhizinate API Price utilized in the formulation of products. Ammonium Glycyrrhizinate API Price is not always fixed or binding as the Ammonium Glycyrrhizinate Price is obtained through a variety of data sources. The Ammonium Glycyrrhizinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ammonium Glycyrrhizinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ammonium Glycyrrhizinate, including repackagers and relabelers. The FDA regulates Ammonium Glycyrrhizinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ammonium Glycyrrhizinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ammonium Glycyrrhizinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ammonium Glycyrrhizinate supplier is an individual or a company that provides Ammonium Glycyrrhizinate active pharmaceutical ingredient (API) or Ammonium Glycyrrhizinate finished formulations upon request. The Ammonium Glycyrrhizinate suppliers may include Ammonium Glycyrrhizinate API manufacturers, exporters, distributors and traders.
click here to find a list of Ammonium Glycyrrhizinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ammonium Glycyrrhizinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ammonium Glycyrrhizinate active pharmaceutical ingredient (API) in detail. Different forms of Ammonium Glycyrrhizinate DMFs exist exist since differing nations have different regulations, such as Ammonium Glycyrrhizinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ammonium Glycyrrhizinate DMF submitted to regulatory agencies in the US is known as a USDMF. Ammonium Glycyrrhizinate USDMF includes data on Ammonium Glycyrrhizinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ammonium Glycyrrhizinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ammonium Glycyrrhizinate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ammonium Glycyrrhizinate Drug Master File in Japan (Ammonium Glycyrrhizinate JDMF) empowers Ammonium Glycyrrhizinate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ammonium Glycyrrhizinate JDMF during the approval evaluation for pharmaceutical products. At the time of Ammonium Glycyrrhizinate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ammonium Glycyrrhizinate suppliers with JDMF on PharmaCompass.
A Ammonium Glycyrrhizinate CEP of the European Pharmacopoeia monograph is often referred to as a Ammonium Glycyrrhizinate Certificate of Suitability (COS). The purpose of a Ammonium Glycyrrhizinate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ammonium Glycyrrhizinate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ammonium Glycyrrhizinate to their clients by showing that a Ammonium Glycyrrhizinate CEP has been issued for it. The manufacturer submits a Ammonium Glycyrrhizinate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ammonium Glycyrrhizinate CEP holder for the record. Additionally, the data presented in the Ammonium Glycyrrhizinate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ammonium Glycyrrhizinate DMF.
A Ammonium Glycyrrhizinate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ammonium Glycyrrhizinate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ammonium Glycyrrhizinate suppliers with CEP (COS) on PharmaCompass.
A Ammonium Glycyrrhizinate written confirmation (Ammonium Glycyrrhizinate WC) is an official document issued by a regulatory agency to a Ammonium Glycyrrhizinate manufacturer, verifying that the manufacturing facility of a Ammonium Glycyrrhizinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ammonium Glycyrrhizinate APIs or Ammonium Glycyrrhizinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ammonium Glycyrrhizinate WC (written confirmation) as part of the regulatory process.
click here to find a list of Ammonium Glycyrrhizinate suppliers with Written Confirmation (WC) on PharmaCompass.
Ammonium Glycyrrhizinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ammonium Glycyrrhizinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ammonium Glycyrrhizinate GMP manufacturer or Ammonium Glycyrrhizinate GMP API supplier for your needs.
A Ammonium Glycyrrhizinate CoA (Certificate of Analysis) is a formal document that attests to Ammonium Glycyrrhizinate's compliance with Ammonium Glycyrrhizinate specifications and serves as a tool for batch-level quality control.
Ammonium Glycyrrhizinate CoA mostly includes findings from lab analyses of a specific batch. For each Ammonium Glycyrrhizinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ammonium Glycyrrhizinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ammonium Glycyrrhizinate EP), Ammonium Glycyrrhizinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ammonium Glycyrrhizinate USP).
